Changes in Clinical Practice in Adherence to the 2014 American Thyroid Association Guidelines on Thyroid Cancer: A Retrospective Study from a Tertiary Referral Center.
Federico CappellacciGian Luigi CanuEleonora NoliAlessandro ArgiolasGiulia PeisMaria Letizia LaiPietro Giorgio CalòFabio MedasPublished in: Journal of personalized medicine (2024)
Thyroidectomy, a pivotal treatment for various thyroid disorders, has seen its indications evolve, particularly with the 2014 American Thyroid Association (ATA) Guidelines advocating for conservative surgical approaches like lobectomy. This retrospective study analyzes thyroidectomy practices at a high-volume center from January 2014 to December 2023, focusing on patients potentially eligible for lobectomy per ATA guidelines. The inclusion criteria were tumors < 4 cm, indeterminate thyroid nodules, or differentiated thyroid carcinoma with clinically uninvolved lymph nodes (cN0). This study analyzed the proportion of patients undergoing lobectomy versus total thyroidectomy (TT) and the oncological outcomes. Of 357 patients, 243 underwent TT and 114 underwent lobectomy. The prevalence of lobectomies rose markedly, comprising 73.9% of surgeries in 2023. TT patients were predominantly female (83.5%) and had higher rates of autoimmune thyroiditis (67.5%) and malignancy (89.7%). Lobectomy patients had larger nodules and more indeterminate cytology. Among 301 malignant cases, TT was associated with higher lymph node metastasis, but similar recurrence rates, compared to lobectomy. This study underscores a shift towards lobectomy, reflecting adherence to ATA guidelines and suggesting conservative surgery is feasible without compromising outcomes. Further research on long-term outcomes and refined patient selection criteria is needed to optimize surgical approaches.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- patients undergoing
- chronic kidney disease
- lymph node metastasis
- lymph node
- healthcare
- primary care
- prognostic factors
- squamous cell carcinoma
- multiple sclerosis
- minimally invasive
- risk factors
- metabolic syndrome
- early stage
- type diabetes
- case report
- patient reported outcomes
- high grade
- robot assisted
- adipose tissue
- radical prostatectomy
- patient reported
- weight loss
- replacement therapy